igf 1 lr3 effet Recombinant human IGF-1 protein (Qk041) IGF-1 LR3 Research: Extended Half-Life

Writingoriginal draft preparation, D.M.-M., H.R.-R., M.M.V.-L

L.NwikeC

Lancet 390:16641675 Aviles-Olmos I, Dickson J, Kefalopoulou Z, Djamshidian A, Ell P, Soderlund T, Whitton P, Wyse R, Isaacs T, Lees A et al (2013) Exenatide and the treatment of patients with Parkinsons disease

It could also benefit people with chronic kidney disease and muscle wasting because of HIV/AIDS

Antioxid Redox Signal 18:522555

Absorption differences: injection vs topical Subcutaneous injection absorption: Rapid absorption into bloodstream Peak plasma concentration: 15-30 minutes 80-90% bioavailability Reaches target tissues quickly Systemic distribution Topical application absorption: Slower penetration through skin barrier Peak tissue concentration: 1-3 hours 5-15% bioavailability (most doesn't penetrate) Primarily local effects (skin where applied) Minimal systemic exposure Absorption comparison table: Why injection more effective: Direct systemic delivery Reaches all tissues Predictable dosing Lower total dose needed Better for body-wide effects When topical makes sense: Face/neck cosmetic use only Avoiding injections Already using skincare routine Combining both approaches (injection + topical) See our GHK-Cu 50mg copper peptide dosage guide for injection protocols